Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board authorizes superintendent to sign on to insulin‑pricing litigation with city
Summary
Norwalk’s school board on July 15 authorized Superintendent Dr. Alexandra Estrella to execute documents to join a class action alleging inflated insulin pricing; district counsel said there is no cost to join and any recovery would be shared between the city, district and affected employees according to calculated losses.
The Norwalk Board of Education on July 15 authorized Superintendent Dr. Alexandra Estrella to execute agreements and engagement letters to retain outside counsel and join a class‑action lawsuit alleging inflated insulin pricing by manufacturers and pharmacy benefit managers.
District counsel and staff said the suit targets insulin manufacturers (Eli Lilly, Novo Nordisk and Sanofi) and pharmacy benefit managers over alleged anti‑competitive or deceptive pricing practices that they say artificially raised insulin costs during a…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
